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Abstract
Background: Lamellar bodies are lysosome-related secretory granules and store lung surfactant
in alveolar type II cells. To better understand the mechanisms of surfactant secretion, we carried
out proteomic analyses of lamellar bodies isolated from rat lungs.
Results: With peptide mass fingerprinting by Matrix Assisted Laser Desorption/Ionization – Time
of Flight mass spectrometry, 44 proteins were identified with high confidence. These proteins fell
into diverse functional categories: surfactant-related, membrane trafficking, calcium binding, signal
transduction, cell structure, ion channels, protein processing and miscellaneous. Selected proteins
were verified by Western blot and immunohistochemistry.
Conclusion: This proteomic profiling of lamellar bodies provides a basis for further investigations
of functional roles of the identified proteins in lamellar body biogenesis and surfactant secretion.
Background
Lung surfactant is a surface active material. It reduces the
surface tension of the air-liquid interface in alveoli, thus
preventing alveoli from collapsing. Deficiency of sur-
factant at the alveolar surface results in respiratory distress
syndromes (RDS) in both newborns and adults [1]. Lung
surfactant is synthesized and secreted by alveolar type II
cells. It is mainly composed of phospholipids and sur-
factant proteins A, B and C (SP-A, SP-B and SP-C). Major
components of surfactant are synthesized in the endoplas-
mic reticulum and stored in specialized organelles called
lamellar bodies [2].
Lamellar bodies are lysosome-related, large secretory
organelles that are 1 to 2 micrometers in size [3]. Similar
to lysosomes, lamellar bodies contain soluble lysosomal
enzymes, such as acid phosphatase and lysosome associ-
ated membrane proteins [3]. Lamellar bodies have an
acidic interior with a pH of about 6.1 or below [4]. How-
ever, lamellar bodies are different from lysosomes in that
they are specialized for storage and secretion of surfactant
rather than for degradation processes. The principal com-
ponents of lamellar bodies, phospholipids, are tightly
packed as concentric arrangements of bi-layer mem-
branes. Secretion of surfactant involves the translocation,
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docking and fusion of lamellar bodies with the apical
plasma membrane [5,6].
The molecular mechanisms that control the exocytosis of
lamellar bodies are still poorly understood [5]. The recent
emergence of powerful proteomic techniques has made it
possible to profile the protein components in a specific
tissue or subcellular organelle [7-9]. To better understand
the regulation of lamellar body biogenesis and exocytosis,
we performed proteomic analysis of lamellar bodies iso-
lated from rat lungs. We carried out both one-dimen-
sional and two-dimensional gel electrophoresis, followed
by Matrix Assisted Laser Desorption/Ionization – Time Of
Flight mass spectrometry (MALDI-TOF) and immunohis-
tochemistry. Here, we report the first proteomic profiling
of lamellar bodies, which will aid in defining the mecha-
nisms of lamellar body exocytosis.
Results
The method used to isolate lamellar bodies was based on
the work of Chander et al. [10] and is in routine use in our
laboratory [11-13]. The isolated lamellar body fraction
consists of intact lamellar bodies and large amounts of
concentric multilamellated membrane structures and
contains no other organelles except for very low amounts
of microsomes.
One-dimensional sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE) staining with colloidal
Coomassie Brilliant Blue revealed more than 50 protein
bands. Due to the complexity of protein components of
lamellar bodies, we also performed two-dimensional
PAGE to get better separation of the proteins. The two-
dimensional gel electophoresis revealed more than 100
spots. Well-resolved protein bands or spots were har-
vested for peptide mass fingerprint analysis. Figs. 1 and 2
show some of the identified proteins from representive
gels.
To identify protein components in lamellar bodies, we
utilized trypsinolytic fingerprinting, MALDI-TOF mass
spectrometry and statistically scored database searching
(Mascot®). Table 1 lists the 44 proteins identified from the
highly purified lamellar bodies. Listed for each protein
include the National Center for Biotechnology Informa-
tion (NCBI) accession number, the number of peptides
matched and percent of sequence covered, the Mascot®
Probability Based Mowse (PBM) score and the molecular
mass. By applying each of these proteomics search criteria,
the proteins were identified with great confidence.
Two-dimensional SDS-PAGE of lamellar body proteins Figure 2
Two-dimensional SDS-PAGE of lamellar body pro-
teins. Isolated lamellar bodies (500 μg of protein) were ana-
lyzed by 2-D polyacrylamide gel electrophoresis. Protein 
spots were visualized by staining with Coomassie Brilliant 
Blue G-250. Isoelectric points (pI) and molecular masses are 
shown on the top and the left of the panel, respectively.
One-dimensional SDS-PAGE of lamellar body proteins Figure 1
One-dimensional SDS-PAGE of lamellar body pro-
teins. Lamellar bodies were isolated from perfused rat lungs 
as described in materials and methods. Approximately 100 
μg of total protein were loaded on 10% Bis-Tris polyacryla-
mide gels. Protein bands were visualized by staining with 
Coomassie Brilliant Blue G-250.BMC Cell Biology 2008, 9:34 http://www.biomedcentral.com/1471-2121/9/34
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Table 1: Proteins identified in lamellar bodies with MALDI-TOF MS
Protein identified NCBI 
accession #
Peptide 
matched
Sequence 
covered %
Mascot 
Score
Molecular 
mass
Ca2+-binding proteins
Annexin A1 P07150 16 42 137 38674
Annexin A2 Q07936 16 49 129 38523
Annexin A3 LURT3 15 45 148 36341
Annexin A4 Q5U362 14 42 140 35871
Annexin A5 P14668 18 52 156 35591
Annexin A6 P48037 14 20 66 75575
Annexin A7 Q6IRJ7 8 17 57 49987
Calreticulin precursor AAH62395 12 24 119 47966
Structural proteins
Actin-beta ATRTC 10 31 97 41724
Vimentin P31000 20 38 119 53569
Myosin-9 (Nonmuscle myosin heavy chain IIa) Q62812 47 24 143 226066
Tropomyosin 1 AAA42289 10 32 60 32938
Moesin (Membrane-organizing extension spike protein) O35763 16 20 64 67566
Cytokeratin 19 AAR36876 15 38 108 44609
Surfactant-related proteins
Surfactant protein A precursor P08427 10 43 63 26272
Surfactant protein B Q6IN44 7 19 62 41590
ABCA3 AAH88202 7 160 240735
Peroxiredoxin-6 NP_446028 8 33 78 24672
Apolipoprotein A-I precursor AAH89820 10 35 84 30043
Apolipoprotein A-IV AAH91159 16 39 122 44429
Lysosome membrane protein II P27615 8 16 52 53925
Ion channels
H+-transporting two-sector ATPase alpha chain precursor J05266 12 29 57 58790
F1-ATPase beta chain 1MABB 10 32 83 49043
Unnamed protein product CAF05438 20 14 113 146309
Membrane traffic
EHD1 AAH82030 11 20 65 60565
Protein processing
Serpinh1 protein Q5RJR9 7 18 56 46532
Dipeptidyl peptidase IV membrane-bound form precursor A39914 15 20 85 90869
Alpha-1-antitrypsin precursor AAA40788 10 24 87 45807
Signal transduction
Mitogen-activated protein kinase kinase 1 interacting protein 1 AAH86353 6 57 65 13571
Rho GDP dissociation inhibitor (GDI) alpha Q5XI73 7 36 90 23393
Rho-associated kinase beta AAB37571 24 18 71 159527
Miscellaneous proteins
Albumin precursor P02770 17 30 128 68674
Poly-ubiquitin Q63654 5 44 82 11234
Complement C3 precursor 625256 13 7 61 186342
Heme-binding 23 K protein (HBP23) 1QQ2A 7 28 58 22095
Putative alpha (1,3) fucosyltransferase CAC81972 10 19 59 42931
Periaxin I58157 19 13 102 146948
Carbonic anhydrase IV AAH97329 10 25 72 35054
Heat shock 70 kDa protein 5 AAH62017 19 33 95 72302
Protein disulfide isomerase associated 3 AAH62393 16 32 95 56588
Transferrin AAP97736 14 19 80 76346
Ferroxidase precursor A35210 11 9 122 120588
RSB-11-77 protein NP_872610 12 28 75 42058
Cytochrome b5 AAB67609 13 27 78 11400BMC Cell Biology 2008, 9:34 http://www.biomedcentral.com/1471-2121/9/34
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The functional classification was performed by a literature
search in the Pubmed database. The functional categories
include calcium-binding proteins, structural proteins, sur-
factant-related proteins, ion channels, membrane traffic,
protein processing, signal transduction and miscellaneous
proteins (Fig. 3).
Based on the availability of antibodies, we selected several
important proteins identified by trypsinolytic fingerprint-
ing from each functional category and verified their iden-
tities by Western blotting and immunohistochemistry.
Actin, Annexin A2, calreticulin, EH domain-containing 1
protein (EHD1), Rho-GDP dissociation inhibitor alpha
(GDI-alpha) and vimentin were confirmed to be present
in lung tissue and lamellar bodies as seen by Western blot
(Fig. 4). Lamellar bodies contain more EHD1 than freshly
isolated type II cell lysate. Only a small portion of GDI-
alpha and actin were present in lamellar bodies, indicat-
ing these proteins were also localized elsewhere in type II
cells. Annexin A2 and calreticulin existed in lamellar bod-
ies and freshly isolated type II cell lysate in a similar
amount. Vimentin was abundantly present in lamellar
bodies, however undetectable in freshly isolated type II
cells. The reason is unclear but could be due to the enrich-
ment of this protein in lamellar bodies and the detection
sensitivity. EHD1 along with the carbonic anhydrase IV
(CAIV) protein were further investigated for their cellular
localization in overnight-cultured type II cells because of
their suitability for double-immunostaining. As seen in
Fig. 5, both EHD1 and CAIV partially colocalized with the
lamellar body marker, LB-180. The localization of these
proteins at lamellar bodies further suggests their roles in
lamellar body function.
Since some of the proteins are developmentally regulated,
we also determined the developmental profiles of two of
the identified proteins (Fig. 6). The protein expression lev-
els of EHD1 peaked postnatally. Calreticulin was
expressed constantly throughout lung development.
Discussion and conclusion
Although proteomic analyses have been performed on
several secretory granules [7-9], proteomic prolifes of
lamellar bodies of alveolar type II cells have remained a
mystery. Here, we have identified 44 proteins present in
lamellar bodies by using one- and two dimensional elec-
trophoresis and trypsinolytic fingerprinting. The identifi-
cation of these proteins provides a basis for further
studying their functions in lamellar body exocytosis and
biogenesis.
The proteins in lamellar bodies fell into diversified func-
tional categories. Several calcium-binding proteins were
identified, including the annexin family and calreticulin.
There are some controversies as to which annexins are
Western blotting of selected proteins identified in lamellar  bodies Figure 4
Western blotting of selected proteins identified in 
lamellar bodies. Lung tissue homogenate (LH), freshly iso-
lated type II cells (T2), and lamellar body fraction (LB) were 
lysed and 20 μg of total protein were separated by 10% SDS-
PAGE and probed with corresponding antibodies.
Pie chart showing the functional classifications Figure 3
Pie chart showing the functional classifications. The 
44 identified proteins were categorized into 8 different func-
tional categories. The pie chart represents the percentage of 
identified proteins under each category. The percentages are 
shown within the pie chart.BMC Cell Biology 2008, 9:34 http://www.biomedcentral.com/1471-2121/9/34
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expressed in alveolar type II cells in literature. We previ-
ously showed that annexin A1, A2, A3, A6, but not A4 and
A5 were present in rat alveolar type II cells as determined
by immunoblotting [14]. However, Sohma et al. were
able to detect annexin A4 in type II cell lysate [15]. Mayran
et al. observed the presence of annexin A1, A4 and A6 in
type II cells by using immunohistochemistry [16]. The
inconsistency is likely due to differences among the anti-
bodies used in the respective experiments. Using the pro-
teomic approach, we identified seven members of the
annexin family, annexin A1-7, in lamellar bodies.
Consistent with its representation in the lamellar body
proteome, annexin A2 is important in various aspects of
membrane trafficking [17]. A series of studies from our
laboratory support a role of annexin A2 in lung surfactant
secretion. It mediates the fusion between lamellar bodies
and the plasma membrane [11,14]. The silencing of
annexin A2 by RNA interference inhibits regulated lung
surfactant secretion [18]. Annexin A2 functions in lung
surfactant secretion via its interaction with SNAP-23 [13].
Disruption of lipid rafts, a platform organizing exocytotic
proteins on a membrane, reduced annexin A2-mediated
fusion of lamellar bodies with the plasma membrane
[12]. In addition to annexin A2, annexin A7 has also been
proposed to be involved in regulating lung surfactant
secretion [19].
We find that annexin A1, A5 and A6 are the components
of the lamellar body proteome. Annexin A1 and A6 have
been reported to play roles in endocytosis [20,21].
Annexin A5 was reported to be secreted from type II cells.
Because its secretion was stimulated by phorbol-12-myr-
istate-13-acetate (PMA) and inhibited by SP-A, showing
the same pattern as that of surfactant secretion [22],
annexin A5 may be released through lamellar bodies.
Annexins play important roles in governing lamellar body
exocytosis and endocytosis, membrane organization,
membrane cytoskeleton linkage and ion conductance.
Developmental profiles of EHD1 and calreticulin in the lung Figure 6
Developmental profiles of EHD1 and calreticulin in 
the lung. Tissues were collected from fetal lungs with gesta-
tional days 18, 19, and 21 (E18, E19, E21) and the lungs from 
newborn (NB), postnatal day 14 (P14) and adult (AD) rats. 
The protein levels of EHD1 and calreticulin were determined 
by Western blot. The β-actin was used as a loading control.
Immunolocalization of selected proteins identified in lamellar bodies Figure 5
Immunolocalization of selected proteins identified in lamellar bodies. Type II cells were cultured overnight on glass 
cover slips. The cells were fixed and subjected to double-labeling with antibodies against EHD1 or CAIV and LB-180 proteins. 
Shown are the representative images indicating the co-localization of EHD1 or CAIV with the LB-180 protein.BMC Cell Biology 2008, 9:34 http://www.biomedcentral.com/1471-2121/9/34
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Soluble N-ethylmaleimide-sensitive fusion protein
attachment protein receptors (SNAREs) are a conserved
mechanism for membrane targeting, docking and fusion
[23]. We have previously shown that the plasma mem-
brane SNAREs, syntaxin 2 and SNAP-23 and their co-fac-
tor, α-SNAP are essential for regulated surfactant secretion
[24,25]. We have also detected the vesicle SNARE, VAMP-
2 in lamellar bodies of type II cells using immunofluores-
ence [26]. However, our proteomic analysis of lamellar
bodies did not show the presence of VAMP-2. The possi-
ble reasons include its low abundance or loss during sam-
ple preparation and separation.
We note that calreticulin is a component of the lamellar
body proteome. Calreticulin is a calcium-binding protein
for calcium storage in the endoplasmic reticulum (ER)
[27]. It has also been reported to act as an important mod-
ulator of the regulation of gene transcription by nuclear
hormone receptors [28]. Consistent with its representa-
tion in our demonstration of the lamellar body proteome,
lamellar bodies contain a high level of calcium, especially
those in the apical area. It was reported that the exocytotic
lamellar bodies contain significantly higher calcium com-
pared to those in the perinuclear area [29]. This suggests
that this high content of calcium in lamellar bodies may
be a supply for the increase in local calcium concentration
during fusion events. Thus, our results indicate that calre-
ticulin may be the main calcium-binding protein in
lamellar bodies and may control the release of calcium
ions during exocytosis.
In agreement with the nature of lamellar bodies as discrete
cytological structures, we identified several cytoskeletal
proteins in lamellar bodies by proteomic analysis. These
proteins include β-actin, myosin-9, tropomysin 1,
moesin, cytokeratin 19 and vimentin. Cytoskeleton is
composed of 3 filamentous structures: actin filaments,
intermediate filaments and microtubes of myosin. It has
been reported that actin [30] and microtubules [31] play
a role in the transportation of lamellar bodies. The cortical
cytoskeleton in type II cells undergoes disassembly and
assembly after being stimulated with lung surfactant
secretagogues [32]. This process is regulated by annexin
A2 and is essential for the lamellar body's access to the
apical plasma membrane. Cytokertain 19 and vimentin
are components of the intermediate filaments [33]. Tro-
pomysin 1 is a ~40 kDa ubiquitous protein that is associ-
ated with the actin filaments and regulates the functions
of actin cytoskeleton [34]. Moesin is a member of the
ezrin/adixin/moesin family and plays a role in the linking
of the plasma membrane and cytoskeleton [35]. These
proteins may also be involved in the movement of lamel-
lar bodies.
Among the major surfactant-related proteins described
here, SP-A and SP-B are known components of lung sur-
factant. However, we did not detect SP-C. This is likely due
to its loss during sample preparation and gel separation
since SP-C is a hydrophobic and low molecular mass pep-
tide. We also observed that several other proteins previ-
ously implicated in lamellar body biogenesis are in fact
part of the lamellar body proteome. ATP-binding cassette
transporter A3 (ABCA3) is a unique type II cell marker
that was originally identified by a monoclonal antibody
screen using lamellar body limited membrane [36]. It
transports lipids into lamellar bodies [37]. ABCA3 muta-
tions result in fatal neonatal lung diseases [38]. Peroxire-
doxin-6, which possesses both phospholipase A2  and
peroxidase activity, is responsible for the degradation of
the main recycled surfactant phospholipid, Dipalmitoyl-
phosphatidylcholine (DPPC), in type II cells [39]. Apoli-
poprotein A is the major apoprotein of high-density-
lipoprotein (HDL) [40]. The identification of apolipopro-
teins in lamellar bodies suggests that the cholesterol of
surfactant may originate from HDL. Our findings suggest
that these proteins are important components of lamellar
bodies, thus demanding closer examination of their roles
in lamellar body structure, function and regulation.
Our results support the idea that lamellar bodies are lyso-
some-related organelles that retain some lysosome-like
features. We note that several lysosome-like proteins are
the components of lamellar bodies. Along with lysosome
membrane protein II [41], some proteases (Dipeptidyl
peptidase IV) [42] and protease inhibitors (Serpinh1 and
alpha-1-antitrypsin precursor) [43,44] were identified,
which suggests that lamellar bodies may not only store
surfactant, but they may also play a role in surfactant
processing. We also identified the vacuolar proton trans-
porting ATPase (V-ATPase) subunit (H+-transporting two-
sector ATPase alpha chain precursor). V-ATPases may
pump protons into lamellar bodies to maintain the low
pH inside lamellar bodies [4,45]., which is essential for
surfactant processing [46,47] and calcium uptake [48].
Our analyses of the lamellar bodies also implicate novel
proteins that may regulate lamellar body function. One is
the EH domain-containing 1 protein (EHD1). The EH
domain includes an EF-calcium-binding motif, a highly
conserved ATP/GTP-binding domain and a central coiled-
coil structure [49]. It has been reported that EHD1 inter-
acts with SNAP-29 and plays a role in the endocytosis of
Insulin-like Growth Factor 1 (IGF1) receptors [50]. Its role
in the regulation of endocytic recycling has been further
confirmed in other systems [51]. While EHD1 has not
been previously implicated in endocytosis of surfactant,
our findings imply that EHD1 may have a role in lamellar
body function.BMC Cell Biology 2008, 9:34 http://www.biomedcentral.com/1471-2121/9/34
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Our indentificatoin of GDI alpha as a major component
of lamellar bodies suggest that it may be involved in the
docking of lamellar bodies at the plasma membrane. Rab
proteins are small GTP-binding proteins that play roles in
vesicular trafficking of molecules between cellular
organelles [52]. They serve as functional switches for the
GTP-GDP exchange reaction. Rab GDP dissociation
inhibitors (GDIs) can reduce the rate of GDP dissociation
from Rab proteins [53]. Rab GDI alpha has been reported
to bind Rab3A and modulates their activity and vesicle-
mediated transport [54]. Small GTP-binding proteins are
associated with lamellar bodies [55]. Rab3D only exists in
subpopulations of lamellar bodies (~25% close to the api-
cal membrane) [56].
Carbonic anhydrase (CA) is a zinc metalloenzyme, which
reversibly catalyses the conversion of CO2 to HCO3 and a
proton [57]. They are predominantly involved in main-
taining acid-base balance. CAII was present in both lung
type I and type II cells [58,59]. CAIV were detected in alve-
olar capillary endothelium but not on large blood vessels
[60]. Our results indicated that CAIV was localized on the
lamellar bodies of type II cells. Lamellar bodies maintain
acidic interiors, which favor not only processing of SP-B
and SP-C but also aggregation of surfactant lipids
[46,47,61]. Thus, the presence of CAIV on lamellar bodies
might be one of the additional mechanisms in maintain-
ing and regulating the acidic interiors.
Our results document the first comprehensive proteome
of the isolated rat lung lamellar bodies. However, lamellar
bodies likely contain proteins that were not detected in
our study due to their low abundance or due to individual
molecular masses and isoelectric point values that hinder
analysis by gel-based techniques. There may also be more
proteins that we could not identify due to the incomplete
nature of the Rattus sequence database. It is also noted
that a few identified proteins have lower molecular
masses than the calculated values. This is probably due to
degradation or processing. Our initial characterization of
the protein constituents of lamellar bodies provides a
platform for further studying lamellar body biogenesis
and surfactant secretion.
Methods
Reagents and chemicals
The ReadyPrep 2-D cleanup kit, ReadyPrep reduction-
alkylation kit, ReadyPrep protein extraction kit, non-lin-
ear pH 3-10 ReadyStrip IPG strips and horse-radish perox-
idase (HPR)-conjugated goat anti-rabbit and anti-mouse
antibodies were from Bio-Rad Laboratories (Hercules,
CA). Rabbit polyclonal anti-β-actin antibodies were from
Sigma (St Louis, MO). Monoclonal anti-annexin A2 and
rabbit polyclonal anti-Rho-GDP dissociation inhibitor
(GDI)-alpha antibodies were from Invitrogen (Carlsbad,
CA). Rabbit polyclonal anti-vimentin, anti-dipeptidyl
peptidase IV (CD26) and anti-calreticulin antibodies were
from Abcam (Cambridge, MA). Polyclonal rabbit anti-EH
domain-containing 1 protein (EHD1) and anti-carbonic
anhydrase IV (CAIV) antibodies were from Santz Cruz
(Santz Cruz, CA). Mouse anti-LB-180 antibody was from
Covance Research Products (Richmond, VA).
Isolation of lamellar bodies from rat lung
Lamellar bodies were isolated from rat lungs by upward
flotation on a discontinuous sucrose gradient, as
described by Chander et al. [10] and Chattopadhyay et al.
[11]. The Oklahoma State University Animal Use and
Care Committee approved all animal procedures used in
this study. A perfused rat lung was homogenized in 1 M
sucrose and loaded at the bottom of a sucrose gradient
(0.2, 0.3, 0.4, 0.5, 0.6, 0.7, and 0.8 M). After centrifuga-
tion at 80,000 × g for 3 hours, the lamellar body fraction
was collected at the 0.4 and 0.5 M interface, and diluted
to 0.24 M with cold water. Lamellar bodies were then
spun down at 20,000 × g  and resuspended in 0.24 M
sucrose containing 10 mM Tris and 50 mM Hepes (pH
7.0). The protein concentration of lamellar bodies was
determined by the RC-DC protein assay (Bio-Rad). We
typically used 6 rats for the isolation of lamellar bodies,
which yielded ~1 mg protein of lamellar bodies.
One-dimensional SDS-PAGE
Lamellar bodies (~100 μg protein) were directly lysed in 1
× SDS sample buffer and fractionated on 10% SDS-PAGE
under reducing conditions. The gel was subjected to col-
loidal coomassie brilliant blue staining to visualize pro-
tein bands as described below.
Two-dimensional gel electrophoresis
Lamellar bodies (~500 μg protein) were processed by the
ReadyPrep 2-D cleanup kit according to the manufac-
turer's protocol. The pellet was air-dried at room temper-
ature and resuspended in an appropriate volume of 2-D
rehydration/sample buffer (8 M Urea, 2% CHAPS, 50 mM
DTT, 0.2% Bio-Lyte 3/10 ampolyte, and 0.002%
bromophenol blue). The non-solubilized particulate mat-
ter was removed by brief centrifugation and the superna-
tant was stored at -80°C or used to passively hydrate 17
cm non-linear, pH 3–10, immobilized pH gradient strips
(IPG) and isoelectric focusing was performed on a Pro-
tean IEF Cell (Bio-Rad). The IPG strips were equilibrated
in equilibration buffers I (6 M urera, 0.375 M Tris, pH 8.8,
2% SDS, 20% glycerol. 2% (w/v) DTT) and II (6 M urera,
0.375 M Tris, pH 8.8, 2% SDS, 20% glycerol, 2.5% (w/v)
iodoacetaminde) and loaded onto 8 – 16% gradient gel
where the proteins were resolved in a secocd dimension
gel electrophoresis. After SDS-PAGE, the gels were fixed
with 40% ethanol and 10% acetic acid overnight, fol-
lowed by washing with water twice for 10 min. The colloi-BMC Cell Biology 2008, 9:34 http://www.biomedcentral.com/1471-2121/9/34
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dal coomassie brilliant staining working solution was
made by mixing 80% stock solution (0.1% coomassie
brilliant blue G-250, 2% ortho-phosphoric acid, 10%
ammonium sulfate) with 20% methanol. The gels were
stained overnight and destained with 1% acetic acid until
satisfactory destaining was achieved.
MALDI-TOF mass spectrometry
Acrylamide bands or spots were harvested, washed with
ammonium bicarbonate and digested for 8 h with 8 μg/
ml trypsin. Trypsonolysis products were extracted and
analyzed by reflectron MALDI-TOF mass spectrometry
(Applied Biosystems DE-Pro) using alpha-cyano-4-
hydroxy cinnamic acid as a matrix. Spectra were calibrated
to 100 ppm mass accuracy using a mix of 5 known pep-
tides (m/z 904 to 2465) spotted proximal to each sample
on the MALDI probes.
Protein identification analysis
Protein identification was carried out by searching the
peptide spectra against the Mass Spectrometry protein
sequence database (MSDB) using the Mascot web based
search engine. The search parameters used were: taxon-
omy, Rattus; allow up to 1 missed cleavage; variable mod-
ifications, carbamidomethyl (C), oxidation (M),
propionamide (C), and pyro-glu (N-term Q); mass value,
MH+; allowed error, 100 ppm.
Alveolar type II cell isolation
Type II cells were isolated from male Sprague-Dawley rats
(180–200 g) as previously described [14]. Briefly, the per-
fused and lavaged lungs were digested with elastase (3 U/
ml) at 37°C. The lung tissues were chopped and filtered
through 160-, 37- and 15-μm mesh size nylon gauze. The
cells were centrifuged, resuspended in culture medium
and panned in a rat IgG-coated bacteriological plastic dish
to remove alveolar macrophages. The unattached cells
were collected. The resultant type II cells had a purity of
>90% and a viability of >95%.
Western blotting
Lung tissue, freshly isolated type II cells and lamellar bod-
ies (20 μg protein each) were fractionated on 10% SDS-
PAGE and transferred to a nitrocellulose membrane. The
membrane was blocked with 5% fat-free milk in Tris-buff-
ered-saline with Tween 20 (TTBS, 20 mM Tris-HCl, pH
7.6, 150 mM NaCl and 0.1% Tween 20). The membrane
was then incubated with appropriate primary antibodies
(β-Actin, 1:2000; Annexin A2, 1:1000; Calreticulin,
1:1000; EHD1, 1:200; GDP-1, 1 μg/ml; Vimentin, 1:500)
at 4°C overnight, and then with secondary antibody
(1:2500) at room temperature for 1 h. Finally, the signal
was developed with ECL reagents and exposed to X-ray
film.
Immunocytochemistry
Type II cells were suspended in DMEM (supplemented
with 10% FBS, non-essential amino acids and antibiotics)
and cultured on glass cover slips overnight. Following cul-
ture, the cells were washed three times with ice-cold 50
mM phosphate buffered saline (PBS) and fixed in 4%
paraformaldehyde at room temperature for 20 min. The
cells were then permeablized with 0.5% Triton X-100 for
20 min at room temperature and then incubated with
10% fetal bovine serum to prevent non-specific binding
of antibodies. The cells were subsequently incubated with
polyclonal rabbit anti-EHD1 or anti-CAIV at 1:50 and
mouse anti-LB-180 at 1:500 overnight at 4°C. After wash-
ing 3 times with PBS for 5 min each, the cells were incu-
bated with alexa 488-conjugated goat anti-rabbit and
Cy3-conjugated goat anti-mouse antibodies at a 1:250
dilution for 1 hour at room temperature. After washing 3
times with PBS, the cover slips were mounted onto glass
slides. Anti-fade solution [60% (v/v) glycerol; 1.5% (w/v)
n-propyl gallate in 50 mM PBS] was added to prevent fad-
ing before sealing the cover slips. Pictures were taken with
a Nikon Eclipse E600 microscope (Nikon, Lewisville, TX).
Negative controls were incubated with secondary anti-
bodies only. Additional controls were included to elimi-
nate the possibility of cross-reactivity among the
antibodies (data not shown).
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